Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea
· Delayed Price · Currency is KRW 1,207.00
+22.00 (1.86%)
At close: May 14, 2025, 3:30 PM KST
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 39.21 billion as of May 13, 2025. Its market cap has decreased by -46.41% in one year.
Market Cap
39.21B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
191.79
Stock Price
1,207.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 39.21B, a decrease of -90.97%. That is a compound annual growth rate of -38.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 39.21B | -56.11% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | 472.24B | 8.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 375.18T |
| SK hynix | 136.77T |
| LG Energy Solution | 73.01T |
| Samsung Biologics | 71.17T |
| Hyundai Motor Company | 43.06T |
| Kia Corporation | 36.89T |
| Hanwha Aerospace | 36.56T |
| HD Hyundai Heavy Industries | 36.35T |